FFIV Q1 2026 Earnings EPS Surges Past Estimates by 1063 as Stock Slips 223 Dermata Therapeutics Q1 2026 Earnings NarrowerthanExpected Loss Supports Ongoing Clinical Development PMTW Q1 2026 Earnings Significant EPS Miss as Trust Reports 016 per Share vs 038 Estimate Sensei Biotherapeutics Inc SNSE Q1 2026 Earnings Deep EPS Miss Reflects Heavy RD Investment and PreRevenue Status Central Garden Pet Company CENTA Q1 2026 Earnings Strong EPS Beat Driven by Operational Efficiency AFBI Q3 2023 Earnings Modest EPS of 025 Amid Quiet Quarter ELTX Q1 2026 Earnings EPS Miss as ClinicalStage Biotech Advances Pipeline Without Revenue PDLB Q4 2025 Earnings Significant EPS Beat Despite Modest Stock Decline CCM Q2 2016 Earnings Deep EPS Miss Amid Positive Stock Movement ABNB Q1 2026 Earnings EPS Misses Estimates Amid Mixed Performance BBSI Q1 2026 Earnings Earnings Beat Estimate Despite Negative EPS LFT Q1 2026 Earnings EPS Miss Weighs on Market Sentiment